Your Web News in One Place

Help Webnuz

Referal links:

Sign up for GreenGeeks web hosting
March 10, 2016 12:00 am GMT

Editas biotech stock drops by 26 percent over CRISPR patent dispute

DNAGene editing outfit Editashas been one of the most successful tech IPOs of 2016 so far, with shares skyrocketing up 130 percent shortly after the company’s public debut. But the stock has now plummeted nearly 26 percent in after-hours tradingover concernsit might not be able to legally use the technology it’s built upon.Some on Twitter believe the drop to be part of a… Read More

Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/zYnWoHSY4SE/

Share this article:    Share on Facebook
View Full Article

Techcrunch

TechCrunch is a leading technology blog, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.

More About this Source Visit Techcrunch